Excessive sequestration of KEAP1 into phase-separated p62 bodies under conditions of impaired autophagy drives persistent ...

Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted ...

A new study published in Nature Aging has uncovered new molecular signatures of frontotemporal dementia by analyzing over ...

A new study reveals the biological secret to the Zika virus's infectious success: Zika uses host cells' own "self-care" ...

US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease: Cranbury, New Jersey Wednesday, May 28, 2025, 14:00 Hrs [IST] Rocket P ...

A new study has revealed a set of proteins in the cerebrospinal fluid that could help identify frontotemporal dementia (FTD) ...

CRANBURY, NJ, USA I May 27, 2025 I Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated ...

Virus’ strategy to maintain persistent infection discovered in Ohio State studyA study by virologists from the Department of ...